)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Phio Pharmaceuticals
Phio Pharmaceuticals (PHIO) investor relations material
Phio Pharmaceuticals Fireside chat summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Fireside chat summary29 Jun, 2026
Introduction and agenda
Audience encouraged to submit questions for the Q&A session at the end of the discussion.
Focus on updates for PH-762, the INTASYL platform, and its unique mechanism and versatility.
Background and experience of the speaker
Dr. Jim Cardia joined RXi after a postdoc at Harvard, attracted by the potential of RNAi technology.
Early work at RXi focused on overcoming delivery challenges for RNAi therapeutics.
Company shifted from platform discovery to clinical development, then pivoted to immuno-oncology.
Current industry trends
Immuno-oncology is a major focus due to recent successes with PD-1 antibodies.
Larger pharmaceutical companies are investing heavily in RNA-based therapeutics.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Phio Pharmaceuticals
- PH-762 demonstrated high safety and efficacy, positioning INTASYL for major skin cancer markets.PHIO
Life Sciences Virtual Investor Forum25 Jun 2026 - Net loss rose to $4.0M as PH-762 Phase 1b completed; cash runway extends into 2027.PHIOQ1 20268 May 2026
- INTASYL siRNA therapy shows promise for localized cancer treatment and future clinical expansion.PHIOFireside chat23 Apr 2026
- RNA immunotherapy achieved 85% response in skin cancer trial; phase II-B/III planned.PHIOSecond Annual Centri Capital Conference14 Apr 2026
- RNA therapy for skin cancer shows 85% response and no toxicities, advancing to pivotal trials.PHIOLife Sciences Virtual Investor Forum12 Mar 2026
- PH-762 Phase 1b trial completed with strong safety data; cash runway extended into 2027.PHIOQ4 20255 Mar 2026
- Reduced losses, PH-762 trial progress, and new financing extend cash runway into Q2 2025.PHIOQ2 20243 Mar 2026
- Net loss narrowed on lower expenses; cash runway into Q2 2025, but more funding needed.PHIOQ3 20243 Mar 2026
- PH-762 clinical trial advanced with strong interim results and improved financial position.PHIOQ4 20243 Mar 2026
Next Phio Pharmaceuticals earnings date
Q2 202611 Aug, 2026
Phio Pharmaceuticals
Next Phio Pharmaceuticals earnings date
Q2 202611 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage